Cited by 1,413Neuroinflammation and Neurodegeneration MechanismsAutophagy in Disease and TherapyGenetics, Aging, and Longevity in Model Organisms

The DOI matches its Crossref record; 98 of the 101 references it cites were found in a registry or an index; 29 of the 47 sources its claims cite were checked for support.

Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain

Open access

Abstract

Microglia become progressively activated and seemingly dysfunctional with age, and genetic studies have linked these cells to the pathogenesis of a growing number of neurodegenerative diseases. Here we report a striking buildup of lipid droplets in microglia with aging in mouse and human brains. These cells, which we call 'lipid-droplet-accumulating microglia' (LDAM), are defective in phagocytosis, produce high levels of reactive oxygen species and secrete proinflammatory cytokines. RNA-sequencing analysis of LDAM revealed a transcriptional profile driven by innate inflammation that is distinct from previously reported microglial states. An unbiased CRISPR-Cas9 screen identified genetic modifiers of lipid droplet formation; surprisingly, variants of several of these genes, including progranulin (GRN), are causes of autosomal-dominant forms of human neurodegenerative diseases. We therefore propose that LDAM contribute to age-related and genetic forms of neurodegeneration.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Aging microglia in mouse and human hippocampus accumulate lipid droplets, defining a lipid droplet-accumulating microglia (LDAM) state with impaired phagocytosis, high ROS, and pro-inflammatory cytokine release. CRISPR-Cas9 screening links lipid droplet formation to neurodegeneration-associated genes, and GRN−/− mice show a similar LDAM-like phenotype.

Key findings

  • Lipid droplets were more abundant in aged mouse hippocampal microglia: BODIPY+ TMEM119+ microglia were 51.95% in aged versus 12.08% in young mice, and CARS+ lipid-storing microglia were 50.76% versus 18.93%; aged human hippocampus also had more Plin2+ Iba1+ microglia.
  • LDAM had a distinct transcriptome with 692 differentially expressed genes between BODIPYlo and BODIPYhi aged microglia; top pathways included phagosome maturation and NO/ROS production, with LPS predicted as the most significant upstream regulator.
  • LDAM showed functional defects: in acute slices, Zymosan+ BODIPY+ microglia were 2.1% versus 24.3% for BODIPY− microglia; LD-hi aged microglia had twofold higher CellROX signal than LD-lo microglia and released more CCL3, CXCL10, IL-6 at baseline plus exaggerated cytokines after LPS.
  • A CRISPR-Cas9 screen identified 112 significant regulators of lipid droplet formation (P<0.05; FDR<50%), including SLC33A1, SNX17, GRN, VPS35, CLN3, and NPC2; GRN−/− mice had twofold more BODIPY+ microglia and twice as many lipid droplets per cell, with LD-hi GRN−/− microglia transcriptionally and functionally similar to LDAM.

Methods

  • Aging mouse microglia were studied by TEM, BODIPY/immunohistochemistry, CARS microscopy, lipidomics, and RNA-seq of FACS-sorted CD11b+CD45lo BODIPYlo versus BODIPYhi hippocampal microglia; human postmortem hippocampus included young adult (<35 years, n=3) and elderly (>60 years, n=5) samples.
  • In vitro and in vivo models included BV2 microglia treated with LPS, Triacsin C, or aged plasma; LPS-treated young mice; organotypic brain slices and hippocampal myelin-debris injection for phagocytosis; CellROX for ROS; multiplex cytokine assays; and a pooled CRISPR-Cas9 screen using iodo-BODIPY photoablation.
  • Analyses used DESeq2 for RNA-seq, IPA/Enrichr for pathways, and GraphPad Prism with t-tests, Mann–Whitney U-tests, or ANOVA followed by Tukey’s post hoc tests.

Limitations

  • The paper states that the role of LDAM in brain aging and disease remains to be defined, that pharmacological and genetic ablation experiments are required, and that mechanisms linking lipid droplets to phagocytosis, ROS, and state conversion remain unresolved.
  • Evident from the text: all animal experiments used male mice only, human tissue was limited to small postmortem samples without neurological or psychiatric diagnoses, and human lipid droplets were detected by Plin2 rather than BODIPY because antigen retrieval removes lipids.
  • Evident from the text: much mechanistic work relies on the BV2 microglial cell line, and the CRISPR screen used an FDR<50% significance threshold; some single-knockout BV2 lines were polyclonal, except GRN knockout cells, which were sub-cloned.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41593-019-0566-1

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

93 Own result · 24 Own interpretation · 14 Own method · 13 No full text of the sources · 10 Couldn’t confirm · 9 Partly supported · 3 Supported · 3 No basis given · 1 Supported so far · accuracy not yet measured

Show all 86 claims

  • It may state two separate claims as one. 51
  • Probably not a substantial claim. 42
  • The quote only partly states this claim. 1
84 of 84
  • The paper relies on this without support.

    Demyelination is a characteristic of brain aging.

    “Because demyelination is a characteristic of brain aging, we analyzed the cholesterol content of lipid droplets in LDAM.”
  • The paper relies on this without support.

    DAM are actively phagocytic populations.

    “LDAM and DAM also show different functional phenotypes; while DAM are actively phagocytic populations, LDAM are severely impaired in this function.”
  • The paper relies on this without support.

    TREM2 and APOE are key genes involved in the progression of neurodegeneration and are upregulated in DAM and MGnD.

    “Furthermore, TREM2 and APOE, two key genes involved in the progression of neurodegeneration that are upregulated in DAM and MGnD, are not regulated in LDAM.”
  • The paper relies on this without support.

    GRN−/− mice is a model for frontotemporal dementia characterized by severe chronic neuroinflammation.

    “Furthermore, we found lipid droplet containing microglia in GRN−/− mice, a model for frontotemporal dementia that is characterized by severe chronic neuroinflammation.”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 101 references

Cited by

Sorted by citations

Items 1,301–1,400 of 1,413

Metadata

Authors
Marschallinger, J., Iram, T., Zardeneta, M., Lee, S. E., Lehallier, B., Haney, M. S., Pluvinage, J. V., Mathur, V., Hahn, O., Morgens, D. W., Kim, J., Tevini, J., Felder, T. K., Wolinski, H., Bertozzi, C. R., Bassik, M. C., Aigner, L., & Wyss-Coray, T.
Affiliations
  • Paracelsus Medical University (AT)
  • Stanford Medicine (US)
  • Stanford University (US)
  • Howard Hughes Medical Institute (US)
  • University of Graz (AT)
Venue
Nature Neuroscience
Published
2020-01-20
Volume
23
Issue
2
Pages
194-208
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W3000061011
Cited by
1,384
References
101
Citations by year
2026: 266 · 2025: 299 · 2024: 263 · 2023: 190 · 2022: 158 · 2021: 141 · 2020: 66
FWCI
45.97
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
Funders
  • Austrian Science Fund (T736)
  • National Institutes of Health (1dp2hd084069-01)
  • National Institute on Aging (AG053015, DP1 AG053015)
  • National Human Genome Research Institute (T32HG000044)
  • National Institute of General Medical Sciences (R37 GM058867, R01GM058867)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (DP2 HD084069)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
microglia, lipid droplets, brain aging, neuroinflammation, phagocytosis, reactive oxygen species, inflammatory cytokines, innate immunity, progranulin, gene regulatory networks, neurodegeneration, hippocampus, CRISPR-Cas9 screen, lipid droplet formation
MeSH terms
Aging, Animals, Brain, Humans, Inflammation, Lipids, Microglia, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-13, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-13 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review